Affiliation:
1. Nursing techniques department, Technical Institute of Al-Diwaniyah, AL-Furat AL Awsat Technical University, Iraq
Abstract
Sex hormones and chronic respiratory diseases play a role in the pathogenesis and the management of Covid-19 infection. Present research tries to shed light on the role of sex hormones, bronchial asthma and lung cancer on the severity of Covid-19 infection and the resulting mortality rate. This study included a follow-up of the health status of 85 patients infected with Covid-19, and all the patients previously diagnosed had hereditary respiratory diseases (bronchial asthma (64) and lung cancer (21)). The serum level of progesterone and testosterone and the stages of lung cancer development were measured in the laboratories of Diwaniyah Teaching Hospital. After conducting medical examinations, computed tomography and x-rays, the severity of Covid-19 infection was classified according to the WHO to moderate, severe and critical infection. The current results showed that most of the hospitalized cases were males (65%) with a death rate (18%), so bronchial asthma was associated with the death rate in males (70% of dead males), followed by postmenopausal (POM) women (66.7% of the dead woman), while pre-menopausal (PRM) women had the highest cure rate (100%). The results of the study showed that the rise in the mean of progesterone in PRM (13.55 ng/ml) was associated with moderate symptoms of Covid-19, while the increased testosterone in males and POM (1018 ng/dL and 67.3 ng/dL, respectively) was associated with an increase in the severity of the infection. In conclusion, asthma and high testosterone directly affected the increase in the severity of Covid-19 and the high mortality rate among the Corona sufferers. While advanced lung cancer had a clear role in that, at the same time, progesterone appeared as a protective factor in young women.
Keywords: Covid-19, bronchial asthma, lung cancer, testosterone, progesterone
Subject
Infectious Diseases,Applied Microbiology and Biotechnology,Epidemiology,Biotechnology
Reference52 articles.
1. 1. Organization, W. H. Coronavirus disease (COVID-19) Situation report. 2020. https ://www.who.int/docs/defau lt-sourc e/coron aviru se/situa tion-repor ts/20200 811-covid -19-sitre p-204.pdf?sfvrs n=1f438 3dd_2.
2. 2. Impact of comorbid asthma on severity of coronavirus disease (COVID‑19). Scientific Reports | (2020) 10:21805 | https://doi.org/10.1038/s41598-020-77791-8.
3. 3. Garg, S.; Kim, L.; Whitaker, M.; et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 – COVID-NET. MMWR Morb Mortal Wkly Rep. 2020, 69: 458–464.
4. 4. Butler, M.W.; O’Reilly, A.; Dunican, E.M.; et al. Prevalence of comorbid asthma in COVID-19 patients. J Allergy Clin Immunol 2020, 146: 334–335.
5. 5. Zhou F., Yu T., Ronghui Du, et al. (2020).Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet, 395:1054–1062.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献